为了加强其生物理性业务，住友化学的美国全资子公司 Valent BioSciences Corp. 与 LidoChem 签订了全球许可协议，并与总部位于阿根廷的 Rizobacter 签订了开发和商业化合作协议。
This is the next step in Valent’s efforts to expand its biorational business in the U.S. which began with the opening a fermentation manufacturing facility in 2014 followed by the acquisition of Mycorrhizal Applications LLC, a producer of mycorrhizal fungal inoculum, in 2015. The company also plans to build a research facility in Illinois, U.S.A. Sumitomo Chemical has also taken steps to strengthen its global agriculture-related business by integrating its plant protection chemicals business and VBC’s biorational business.
更多关于 Sumitomo’s plans.